• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA releases draft Sunshine Law guidelines

FDA releases draft Sunshine Law guidelines

April 9, 2013 By Sony Salzman

Sunshine Act

The FDA published a draft of its financial disclosure guidelines, due to take effect by August , that parallel the healthcare reform law’s Sunshine Act.

The 35-page document details all physician-relationship rules companies will have to follow when applying for marketing applications with the FDA.

The document seeks to answer lingering questions about how reporting should be carried out, how bias is determined and which physician/manufacturer relationships must be reported. The guidance has been updated from a May 2011 version, based on recommendations from 13 individuals and interested parties, according to the federal watchdog agency.

The guidelines define the specific compensation, payments, parties involved and all other information that will need to be reported under the FDA’s internal rules, apart from any requirements mandated by the Physicians Payment Sunshine Act provision of the Affordable Care Act, which requires public disclosure of payments and gifts to physicians.

According to a survey published last month, more than half of physicians are concerned about public exposure of the doctor/industry relationship, especially considering that Obamacare’s transparency rules were published some 15 months behind schedule.

Companies undergoing a clinical study must report any physician compensation that might change based on the outcome of the study, or any payments made to investigators with proprietary or stock interested in the company, according to the draft guidance. Companies will also need to report any study sponsor with more than $50,000 worth of equity in the company, and all payments to investigators that exceed $25,000.

If the federal watchdog agency suspects that physician relationships have skewed the outcome of the study, it can audit the data, request further data on the study or require a separate study on the data in question. The FDA can also refuse to consider the study data in the application all together, according to the draft guidance.

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: Physician Payment Sunshine Act, Sunshine Laws

More recent news

  • Mount Sinai adopts Flosonics wearable ultrasound device
  • GE HealthCare launches next-gen intraoperative ultrasound
  • Philips launches new point-of-care ultrasound system
  • Medtronic to invest $50M in India Diabetes center
  • Corvia Medical raises $55M as it seeks FDA nod for atrial shunt

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy